Seeking Alpha

RIGL
Rigel Pharmaceuticals, Inc. - NASDAQ

4/16/2014, 3:33 AM ET
Quote & Analysis Breaking News StockTalk
rigl chart
Today 5d 1m 3m 1y 5y 10y
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
FOCUS  |  RELATED  |  TRANSCRIPTS  |  OTHER NEWS & PR
There are no Transcripts on RIGL.
RIGL vs. ETF Alternatives
Company Description

Rigel Pharmaceuticals, Inc., is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory/autoimmune diseases, as well as for certain cancers and metabolic diseases.